Skip to content
healthcare.dev

KYMBEE

NDC 0245-0813, Deflazacort, suspension, from Upsher-Smith Laboratories, LLC.

Product NDC
0245-0813
Status
Listed
Labeler
Upsher-Smith Laboratories, LLC
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216992
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0245-0813 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFLAZACORT22.75 mg/mL

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

Package NDCNDC-11Package
0245-0813-13002450813131 BOTTLE in 1 CARTON (0245-0813-13) / 13 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ba749cfb-813d-4799-9e7b-44ede92065f2

Use it

Look up 0245-0813 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0245-0813 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0245-0813. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.